0000899866-20-000063.txt : 20200609 0000899866-20-000063.hdr.sgml : 20200609 20200609165959 ACCESSION NUMBER: 0000899866-20-000063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200608 FILED AS OF DATE: 20200609 DATE AS OF CHANGE: 20200609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ORLOFF JOHN J CENTRAL INDEX KEY: 0001643941 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 20952601 MAIL ADDRESS: STREET 1: C/O BAXALTA INCORPORATED STREET 2: 1200 LAKESIDE DRIVE CITY: BANNOCKBURN STATE: IL ZIP: 60015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 4752302596 MAIL ADDRESS: STREET 1: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: ALEXION PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960111 4 1 wf-form4_159173638161609.xml FORM 4 X0306 4 2020-06-08 0 0000899866 ALEXION PHARMACEUTICALS, INC. ALXN 0001643941 ORLOFF JOHN J C/O ALEXION PHARMACEUTICALS, INC 121 SEAPORT BOULEVARD BOSTON MA 02210 0 1 0 0 EVP, Research & Development Common Stock, par value $.0001 per share 2020-06-08 4 F 0 2784 114.61 D 44529 D This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units. /s/ Douglas Barry, Attorney-in-Fact for John Orloff 2020-06-09